Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Santis

Showing results (101-110 of 278) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Immunology|April 26, 2021
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritisNatasa Isailovic, Angela Ceribelli, Gilberto Cincinelli, et al.
Future Oncology (London, England)|May 11, 2026
Real-world treatment patterns for metastatic urothelial cancer in 5 European countries: EVEREST 2Maria De Santis, Neil Milloy, Maria Walley, et al.
Lancet (London, England)|September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatmentsEva Compérat, Mahul B Amin, Richard Cathomas, et al.
European Urology|April 2, 2011
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelinesArnulf Stenzl, Nigel C Cowan, Maria De Santis, et al.
Clinical Reviews in Allergy & Immunology|January 28, 2022
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart InvolvementMaria Elena Laino, Angela Ammirabile, Francesca Motta, et al.
Seminars in Arthritis and Rheumatism|May 28, 2024
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to knowAntonio Tonutti, Nicola Pugliese, Angela Ceribelli, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
Annals of Nuclear Medicine|December 22, 2020
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with <sup>177</sup>Lu-labeled prostate-specific membrane antigenKai Huang, Imke Schatka, Julian M M Rogasch, et al.
Arthritis Research & Therapy|January 4, 2025
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and genderNicoletta Luciano, Elisa Barone, Enrico Brunetta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 18, 2019
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et alMaria De Santis, Natasa Isailovic, Elena Generali, et al.
Pageof 28

Showing results (101-110 of 278) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Immunology|April 26, 2021
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritisNatasa Isailovic, Angela Ceribelli, Gilberto Cincinelli, et al.
Future Oncology (London, England)|May 11, 2026
Real-world treatment patterns for metastatic urothelial cancer in 5 European countries: EVEREST 2Maria De Santis, Neil Milloy, Maria Walley, et al.
Lancet (London, England)|September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatmentsEva Compérat, Mahul B Amin, Richard Cathomas, et al.
European Urology|April 2, 2011
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelinesArnulf Stenzl, Nigel C Cowan, Maria De Santis, et al.
Clinical Reviews in Allergy & Immunology|January 28, 2022
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart InvolvementMaria Elena Laino, Angela Ammirabile, Francesca Motta, et al.
Seminars in Arthritis and Rheumatism|May 28, 2024
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to knowAntonio Tonutti, Nicola Pugliese, Angela Ceribelli, et al.
European Journal of Radiology|April 20, 2005
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residualsAlexander Becherer, Maria De Santis, Georgios Karanikas, et al.
Annals of Nuclear Medicine|December 22, 2020
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with <sup>177</sup>Lu-labeled prostate-specific membrane antigenKai Huang, Imke Schatka, Julian M M Rogasch, et al.
Arthritis Research & Therapy|January 4, 2025
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and genderNicoletta Luciano, Elisa Barone, Enrico Brunetta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 18, 2019
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et alMaria De Santis, Natasa Isailovic, Elena Generali, et al.
Pageof 28